Directory  |   Consumers  |   FAQ  

NPRA Banner

               
Product Search   QUEST3+ System   Enquiries   Sitemap  

Reaksi Drug Safety News 2017 - Issue 5/2017

Hits: 12784

User Rating: 1 / 5

Star ActiveStar InactiveStar InactiveStar InactiveStar Inactive
 

Reaksi Drug Safety News 2017,

Issue 5/2017

 

  • Vemurafenib: Risk of Dupuytren’s Contracture and Plantar Fascial Fibromatosis
  • Leflunomide and Teriflunomide: Risk of Falsely Decreased Ionised Calcium Levels and Risk of Colitis

 



 		  
  DOWNLOAD PDF

 

 

 

Rating:
( 1 Rating )

 

National Pharmaceutical Regulatory Agency (NPRA)

Lot 36, Jalan Universiti (Jalan Prof Diraja Ungku Aziz), 46200 Petaling Jaya, Selangor, Malaysia.

  • Phone: +603-7883 5400

 

 

More Links

Our Location

Public Enquiry

Privacy & Policy

Archives

More Links

DISCLAIMER

The Government of Malaysia and the National Pharmaceutical Regulatory Agency are not responsible for any loss or damage caused by the usage of any information obtained from this website.

Mobile Web :

NPRA Product StatusNPRA Product Status

NPRA Product Status

Site Last Modified

  • Last Modified: Thursday 21 November 2024, 14:55:22.

Online Services

Search

Main Menu English

Choose Your Language